These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 285593)

  • 1. Cost of care of the hypertensive in the primary preventive trial, Gothenburg.
    Wilhelmsen L; Berglund G; Wedel H
    Acta Med Scand Suppl; 1979; 626():44-6. PubMed ID: 285593
    [No Abstract]   [Full Text] [Related]  

  • 2. Mild hypertension--early drug treatment or follow-up only? The Oslo study.
    Helgeland A; Aasen IB; Leren P
    Acta Med Scand Suppl; 1979; 626():34-6. PubMed ID: 285589
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
    Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B;
    Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hypertension in Sweden: treatment of patients with hypertension costs more than a billion crowns per year].
    Johannesson M; Borgqvist L; Jönsson B; Råstam L
    Lakartidningen; 1991 Mar; 88(12):1103-6. PubMed ID: 2016946
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study.
    McInnes G; Burke TA; Carides G
    J Hum Hypertens; 2006 Jan; 20(1):51-8. PubMed ID: 16357874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hypertension at a health center. 2: The patients' expenses in connection with transport and time are more than a tenth of the total treatment costs].
    Johannesson M; Borgquist L; Elenstål A; Jönsson B; Tilling B
    Lakartidningen; 1991 Mar; 88(12):1098, 1100-1, 1103. PubMed ID: 2016945
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hypertension at a health center. 1: The drugs prescribed for men are much more expensive than the ones prescribed for women].
    Johannesson M; Borgquist L; Elenstål A; Jönsson B; Tilling B
    Lakartidningen; 1991 Mar; 88(12):1096-8. PubMed ID: 2016944
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical importance of direct hospital costs in patients with arterial hypertension in a university hospital, Rio de Janeiro, Brazil].
    de Souza e Silva NA; Aguiar GR; Nogueira Ada R; Duarte MM; Alves RH
    Rev Saude Publica; 1986 Aug; 20(4):293-302. PubMed ID: 3576101
    [No Abstract]   [Full Text] [Related]  

  • 9. [What is the cost of hypertension treatment to society?].
    Aberg H
    Lakartidningen; 1991 Mar; 88(12):1055-6. PubMed ID: 2016931
    [No Abstract]   [Full Text] [Related]  

  • 10. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care?
    Lorgelly P; Siatis I; Brooks A; Slinn B; Millar-Craig MW; Donnelly R; Manning G
    Br J Gen Pract; 2003 Oct; 53(495):794-6. PubMed ID: 14601356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Care of hypertensives in Dalby: organisation and health economic aspects.
    Nilsson P; Kandell-Collén A; Lindholm LH; Scherstén B
    J Hum Hypertens; 1993 Dec; 7(6):551-4. PubMed ID: 8114045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.
    Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B;
    Heart; 2008 Feb; 94(2):e4. PubMed ID: 17916665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of heart attacks. A multifactorial preventive trial in Gothenburg, Sweden.
    Werkö L
    Ann Clin Res; 1979 Apr; 11(2):71-9. PubMed ID: 453782
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatment.
    Johannesson M
    J Hum Hypertens; 1996 Feb; 10 Suppl 2():S23-6. PubMed ID: 8868040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
    Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R
    Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economics of hypertension control.
    Fletcher A
    J Med Liban; 1994; 42(3):138-44. PubMed ID: 7629847
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of costs and effectiveness of an integrated outpatient training program for hypertensive patients].
    Kurz RW; Pirker H; Pötz H; Dörrscheidt W; Uhlir H
    Wien Klin Wochenschr; 2005 Aug; 117(15-16):526-33. PubMed ID: 16158203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost of cardiovascular risk factor prevention in middle-aged French men. The PRIME study].
    Marques-Vidal P; Arveiler D; Amouyel P; Ducimetière P; Ferrières J
    Rev Epidemiol Sante Publique; 2001 Dec; 49(6):541-9. PubMed ID: 11845103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cost of arterial hypertension in Spain].
    Badía X; Rovira J; Tresserras R; Trinxet C; Segú JL; Pardell H
    Med Clin (Barc); 1992 Dec; 99(20):769-73. PubMed ID: 1369787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of medical care for patients with diabetes, hypertension and both conditions: does alcohol use play a role?
    French MT; Mundt MP; Fleming M; Zavala SK
    J Intern Med; 2005 Jul; 258(1):45-54. PubMed ID: 15953132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.